These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 26846987

  • 1. Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients.
    Hojjat SP, Cantrell CG, Carroll TJ, Vitorino R, Feinstein A, Zhang L, Symons SP, Morrow SA, Lee L, O'Connor P, Aviv RI.
    Mult Scler; 2016 Nov; 22(13):1685-1694. PubMed ID: 26846987
    [Abstract] [Full Text] [Related]

  • 2. Spatial Correlation of Pathology and Perfusion Changes within the Cortex and White Matter in Multiple Sclerosis.
    Mulholland AD, Vitorino R, Hojjat SP, Ma AY, Zhang L, Lee L, Carroll TJ, Cantrell CG, Figley CR, Aviv RI.
    AJNR Am J Neuroradiol; 2018 Jan; 39(1):91-96. PubMed ID: 29097413
    [Abstract] [Full Text] [Related]

  • 3. Regional reduction in cortical blood flow among cognitively impaired adults with relapsing-remitting multiple sclerosis patients.
    Hojjat SP, Cantrell CG, Vitorino R, Feinstein A, Shirzadi Z, MacIntosh BJ, Crane DE, Zhang L, Morrow SA, Lee L, O'Connor P, Carroll TJ, Aviv RI.
    Mult Scler; 2016 Oct; 22(11):1421-1428. PubMed ID: 26754799
    [Abstract] [Full Text] [Related]

  • 4. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
    Hojjat SP, Kincal M, Vitorino R, Cantrell CG, Feinstein A, Zhang L, Lee L, O'Connor P, Carroll TJ, Aviv RI.
    AJNR Am J Neuroradiol; 2016 Aug; 37(8):1454-61. PubMed ID: 27012299
    [Abstract] [Full Text] [Related]

  • 5. DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS.
    Preziosa P, Pagani E, Morelli ME, Copetti M, Martinelli V, Pirro F, Falini A, Comi G, Filippi M, Rocca MA.
    Mult Scler; 2017 Dec; 23(14):1918-1928. PubMed ID: 28098510
    [Abstract] [Full Text] [Related]

  • 6. The relationship between white matter fiber damage and gray matter perfusion in large-scale functionally defined networks in multiple sclerosis.
    Ma AY, Vitorino RC, Hojjat SP, Mulholland AD, Zhang L, Lee L, Carroll TJ, Cantrell CG, Figley CR, Aviv RI.
    Mult Scler; 2017 Dec; 23(14):1884-1892. PubMed ID: 28178867
    [Abstract] [Full Text] [Related]

  • 7. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
    Al-Radaideh A, Athamneh I, Alabadi H, Hbahbih M.
    Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
    [Abstract] [Full Text] [Related]

  • 8. Dynamic Contrast-Enhanced Magnetic Resonance Imaging Suggests Normal Perfusion in Normal-Appearing White Matter in Multiple Sclerosis.
    Ingrisch M, Sourbron S, Herberich S, Schneider MJ, Kümpfel T, Hohlfeld R, Reiser MF, Ertl-Wagner B.
    Invest Radiol; 2017 Mar; 52(3):135-141. PubMed ID: 27548346
    [Abstract] [Full Text] [Related]

  • 9. Normal appearing white matter permeability: a marker of inflammation and information processing speed deficit among relapsing remitting multiple sclerosis patients.
    Eftekhari E, Hojjat SP, Vitorino R, Carroll TJ, Cantrell CG, Lee L, Taylor MW, Morrow SA, Benhabib H, Aviv RI, Kassner A.
    Neuroradiology; 2017 Aug; 59(8):771-780. PubMed ID: 28623483
    [Abstract] [Full Text] [Related]

  • 10. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A, Müller-Lenke N, Naegelin Y, Kalt G, Bendfeldt K, Kuster P, Stoecklin M, Gass A, Sprenger T, Radue EW, Kappos L, Penner IK.
    Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
    [Abstract] [Full Text] [Related]

  • 11. Contribution of Gray and White Matter Abnormalities to Cognitive Impairment in Multiple Sclerosis.
    Zhang X, Zhang F, Huang D, Wu L, Ma L, Liu H, Zhao Y, Yu S, Shi J.
    Int J Mol Sci; 2016 Dec 27; 18(1):. PubMed ID: 28035997
    [Abstract] [Full Text] [Related]

  • 12. Clinical and MRI predictors of cognitive decline in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study.
    Dong X, Xu G, Wang J, Yin N, Meng N.
    Mult Scler Relat Disord; 2022 Sep 27; 65():103838. PubMed ID: 35749960
    [Abstract] [Full Text] [Related]

  • 13. Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study.
    Tillema JM, Hulst HE, Rocca MA, Vrenken H, Steenwijk MD, Damjanovic D, Enzinger C, Ropele S, Tedeschi G, Gallo A, Ciccarelli O, Rovira A, Montalban X, de Stefano N, Stromillo ML, Filippi M, Barkhof F, MAGNIMS Study Group.
    Mult Scler; 2016 Jun 27; 22(7):901-9. PubMed ID: 26432859
    [Abstract] [Full Text] [Related]

  • 14. Comparison of Quantitative Cerebral Blood Flow Measurements Performed by Bookend Dynamic Susceptibility Contrast and Arterial Spin-Labeling MRI in Relapsing-Remitting Multiple Sclerosis.
    D'Ortenzio RM, Hojjat SP, Vitorino R, Cantrell CG, Lee L, Feinstein A, O'Connor P, Carroll TJ, Aviv RI.
    AJNR Am J Neuroradiol; 2016 Dec 27; 37(12):2265-2272. PubMed ID: 27686489
    [Abstract] [Full Text] [Related]

  • 15. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
    Sacco R, Bisecco A, Corbo D, Della Corte M, d'Ambrosio A, Docimo R, Gallo A, Esposito F, Esposito S, Cirillo M, Lavorgna L, Tedeschi G, Bonavita S.
    J Neurol; 2015 Jul 27; 262(7):1691-7. PubMed ID: 25957638
    [Abstract] [Full Text] [Related]

  • 16. Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study.
    Damjanovic D, Valsasina P, Rocca MA, Stromillo ML, Gallo A, Enzinger C, Hulst HE, Rovira A, Muhlert N, De Stefano N, Bisecco A, Fazekas F, Arévalo MJ, Yousry TA, Filippi M.
    AJNR Am J Neuroradiol; 2017 Jan 27; 38(1):18-24. PubMed ID: 27686487
    [Abstract] [Full Text] [Related]

  • 17. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC, van Geest Q, Dekker I, Steenwijk MD, Meijer KA, Hulst HE, Barkhof F, Uitdehaag BMJ, Schoonheim MM, Geurts JJG.
    Brain; 2018 Sep 01; 141(9):2605-2618. PubMed ID: 30169585
    [Abstract] [Full Text] [Related]

  • 18. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
    Wen J, Yablonskiy DA, Luo J, Lancia S, Hildebolt C, Cross AH.
    Neuroimage Clin; 2015 Sep 01; 9():164-75. PubMed ID: 27330979
    [Abstract] [Full Text] [Related]

  • 19. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.
    Riccitelli GC, Pagani E, Rodegher M, Colombo B, Preziosa P, Falini A, Comi G, Filippi M, Rocca MA.
    Mult Scler; 2019 Feb 01; 25(2):204-216. PubMed ID: 29173009
    [Abstract] [Full Text] [Related]

  • 20. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC, Gold SM, Lee B, Montag M, Horsfall J, O'Connor MF, Sicotte NL.
    Neuroimage Clin; 2015 Feb 01; 8():440-7. PubMed ID: 26106524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.